How nerve signals may trigger the body’s own anandamide

N-Arachidonoyl-phosphatidylethanolamide phospholipase D activation by muscarinic receptors.

The Journal of physiology • • Highly Relevant
🤖

AI Summary

This study examined how the body produces anandamide, one of its two major endocannabinoid messengers. In human kidney-derived cells, activating muscarinic M3 receptors—a type of receptor stimulated by the neurotransmitter acetylcholine—triggered an endocannabinoid signal only when the cells contained the enzyme NAPE-PLD. The response was reduced by a NAPE-PLD inhibitor and depended on phospholipase C and calcium released from internal stores.

The researchers also found the same pattern in lacrimal and salivary glands, where M3 receptors and NAPE-PLD were present in the same cells. Sensor experiments indicated that the glands produced anandamide, rather than 2-AG, after muscarinic stimulation. The findings suggest that acetylcholine-driven nerve activity may engage anandamide as a local feedback signal, potentially helping regulate gland function and neurotransmitter release. This was a cell and tissue study—not a clinical trial—so it does not show that cannabis, THC, or CBD produces the same effects in people, and the abstract reports no clinical outcomes or quantitative effect sizes.

💡 Key Findings

1
Activating muscarinic M3 receptors stimulated NAPE-PLD to produce anandamide in engineered human cells.
Moderate
55%
2
The cellular response required phospholipase C activity and calcium from internal stores, indicating a specific Gq signaling pathway.
Moderate
55%
3
Lacrimal and salivary gland tissues also produced an anandamide-specific signal after muscarinic stimulation, supporting that this mechanism occurs in native tissue.
Moderate
55%
4
The findings identify a possible endocannabinoid feedback mechanism that could help regulate acetylcholine signaling, but they do not demonstrate a direct effect of cannabis products in humans.
Moderate
50%

📄 Original Abstract

The endogenous cannabinoid signalling system consists of G protein-coupled receptors, messengers - 2-arachidonoylglycerol (2-AG) and anandamide - and enzymatic machinery to synthesize and metabolize these messengers. Anandamide is physiologically important, but its synthesis is incompletely understood. N-Arachidonoyl-phosphatidylethanolamide phospholipase D (NAPE-PLD) synthesizes acylethanolamines, including anandamide, but how is NAPE-PLD activated? We used genetically encoded G protein-coupled receptor based (GRAB) sensors for endocannabinoids (eCBs) and immunohistochemistry to investigate. Human embryonic kidney 293 (HEK293) cells natively express Gq-coupled muscarinic M3 receptors. The muscarinic agonist oxotremorine-M stimulated the GRABeCB sensor only when HEK293 cells were cotransfected with NAPE-PLD. This signal was reduced by the NAPE-PLD inhibitor LEI401 and required both phospholipase C and internal calcium stores. Gq-coupled mGluR5 glutamate receptors effectively substitute for M3 receptors. Thus M3 receptors stimulate NAPE-PLD synthesis of acylethanolamines such as anandamide via Gq signalling pathways resembling those for 2-arachidonoylglycerol. Parasympathetic activation stimulates tearing and salivation via M3 receptors on myoepithelial cells. The cannabinoid signalling system may act as a feedback inhibitor to inhibit acetylcholine release, but the identity and source of the endogenous cannabinoid messenger are uncertain. NAPE-PLD and M3 proteins colocalize in myoepithelial cells; fatty acid amide hydrolase (FAAH) resides in glandular acinar cells. Oxotremorine-M stimulation of lacrimal or submandibular salivary glands co-cultured with HEK293-GRABeCB cells stimulated GRABeCB responses. This response was diminished by LEI401 and was also present in cells expressing GRABAEA, an anandamide-specific sensor, but not those expressing GRAB2AG. We conclude that muscarinic M3 receptors stimulate NAPE-PLD to produce anandamide in cell lines and exocrine glands. This means of stimulating anandamide synthesis may play many roles in the body. KEY POINTS: The cannabinoid signalling system plays important roles in the body and in doing so makes use of two endogenous messengers, 2-arachidonoylglycerol (2-AG) and anandamide. The regulation of anandamide synthesis is still poorly understood. This study demonstrates that muscarinic Gq-coupled GPCRs can stimulate anandamide production by activating the enzyme N-arachidonoyl-phosphatidylethanolamide phospholipase D (NAPE-PLD) and further shows that this occurs natively in salivary and lacrimal glands. Muscarinic Gq-coupled G protein-coupled receptor (GPCR) activation of NAPE-PLD to induce anandamide synthesis may play many roles in the body.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.